Camden National Bank’s Edwards Lifesciences EW Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-80,191	Closed	-$7.41M	–	172
2024 Q2	$7.41M	Buy	80,191 +9,845	+14%	+$872K	1.14%	45
2024 Q1	$6.72M	Sell	70,346 -519	-0.7%	-$43.6K	1.19%	42
2023 Q4	$5.4M	Sell	70,865 -2,420	-3%	-$168K	1.01%	48
2023 Q3	$5.08M	Buy	73,285 +149	+0.2%	+$12K	1.04%	47
2023 Q2	$6.9M	Sell	73,136 -653	-0.9%	-$56.8K	1.35%	33
2023 Q1	$6.1M	Buy	73,789 +678	+0.9%	+$53.3K	1.24%	38
2022 Q4	$5.46M	Sell	73,111 -2,289	-3%	-$176K	1.14%	43
2022 Q3	$6.23M	Buy	75,400 +277	+0.4%	+$26.7K	1.39%	32
2022 Q2	$7.14M	Buy	75,123 +688	+0.9%	+$71.2K	1.48%	25
2022 Q1	$8.76M	Sell	74,435 -163	-0.2%	-$18.3K	1.59%	22
2021 Q4	$9.66M	Sell	74,598 -1,068	-1%	-$125K	1.7%	17
2021 Q3	$8.57M	Sell	75,666 -751	-1%	-$85.7K	1.65%	21
2021 Q2	$7.91M	Sell	76,417 -1,556	-2%	-$147K	1.49%	25
2021 Q1	$6.52M	Buy	77,973 +709	+0.9%	+$59.9K	1.3%	37
2020 Q4	$7.05M	Sell	77,264 -2,130	-3%	-$177K	1.47%	28
2020 Q3	$6.34M	Buy	79,394 +48,274	+155%	+$3.77M	1.4%	29
2020 Q2	$2.15M	Buy	+31,120	New	+$2.21M	0.53%	52